title: Usefulness of PET Imaging to Guide Treatment Options in Gliomas.
abstract: Magnetic resonance imaging (MRI) is the gold standard guiding diagnostic and therapeutic management in glioma with its high resolution and possibility to depict blood-brain-barrier disruption when contrast medium is applied. In light of the shifting paradigms revealing distinct tumor subtypes based on the molecular and genetic characterization and increasing knowledge about the variability of glioma biology, additional imaging modalities such as positron emission tomography (PET) depicting metabolic processes gain further importance in the management of glioma.
authors.affiliation: Department of Neurosurgery, University Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany. bogdana.suchorska@med.uni-muenchen.de.
authors.forename: Bogdana
authors.initials: B
authors.lastname: Suchorska
authors.affiliation: Department of Nuclear Medicine, University Hospital Munich, Munich, Germany.
authors.forename: Nathalie Lisa
authors.initials: NL
authors.lastname: Albert
authors.affiliation: Department of Neurosurgery, University Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany.
authors.forename: Jörg-Christian
authors.initials: JC
authors.lastname: Tonn
keywords: Glioma; Imaging; PET
references.citation: Clin Cancer Res. 2004 Nov 1;10(21):7163-70
references.pmid: 15534088
references.citation: J Nucl Med. 2004 Aug;45(8):1293-8
references.pmid: 15299051
references.citation: Eur J Nucl Med Mol Imaging. 2007 Dec;34(12 ):1933-42
references.pmid: 17763848
references.citation: Stereotact Funct Neurosurg. 1999;73(1-4):148-53
references.pmid: 10853123
references.citation: J Nucl Med. 2013 Jul;54(7):1007-10
references.pmid: 23708197
references.citation: Mol Imaging. 2013 May;12(3):137-47
references.pmid: 23490440
references.citation: AJNR Am J Neuroradiol. 2008 Nov;29(10 ):1867-71
references.pmid: 18687745
references.citation: J Neurosurg. 1993 Dec;79(6):853-8
references.pmid: 8246053
references.citation: Childs Nerv Syst. 2007 Jul;23 (7):739-51
references.pmid: 17356889
references.citation: Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1021-9
references.pmid: 22491781
references.citation: BMC Clin Pathol. 2012 Feb 28;12:4
references.pmid: 22373026
references.citation: Brain. 2005 Mar;128(Pt 3):678-87
references.pmid: 15689365
references.citation: J Clin Oncol. 1990 Jul;8(7):1277-80
references.pmid: 2358840
references.citation: Amino Acids. 2015 Feb;47(2):335-44
references.pmid: 25385314
references.citation: J Clin Oncol. 2009 Dec 10;27(35):5861-2
references.pmid: 19901101
references.citation: J Nucl Med. 2006 Jun;47(6):904-11
references.pmid: 16741298
references.citation: J Clin Oncol. 2010 Apr 10;28(11):1963-72
references.pmid: 20231676
references.citation: Eur J Nucl Med Mol Imaging. 2007 Dec;34(12 ):2082-7
references.pmid: 17763978
references.citation: Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):64-74
references.pmid: 16111573
references.citation: J Neurooncol. 2010 Sep;99(2):217-25
references.pmid: 20091333
references.citation: J Nucl Med. 1980 Jul;21(7):670-5
references.pmid: 7391842
references.citation: J Nucl Med. 2006 Mar;47(3):393-403
references.pmid: 16513607
references.citation: Neurology. 1998 May;50(5):1316-22
references.pmid: 9595980
references.citation: AJNR Am J Neuroradiol. 2008 Jun;29(6):1176-82
references.pmid: 18388218
references.citation: Neuro Oncol. 2016 Mar;18(3):426-34
references.pmid: 26243791
references.citation: J Nucl Med. 2007 Oct;48(10 ):1651-61
references.pmid: 17873130
references.citation: J Nucl Med. 2015 Jan;56(1):9-15
references.pmid: 25537990
references.citation: J Neurosurg. 1999 Nov;91(5):797-803
references.pmid: 10541237
references.citation: Acta Neurochir (Wien). 1995;134(1-2):79-82
references.pmid: 7668134
references.citation: Neuro Oncol. 2014 Mar;16(3):434-40
references.pmid: 24305717
references.citation: Neuroradiology. 1992;34(6):463-9
references.pmid: 1436452
references.citation: Lancet Oncol. 2014 Aug;15(9):e395-403
references.pmid: 25079102
references.citation: J Neurosurg. 1995 Mar;82(3):445-52
references.pmid: 7861223
references.citation: Neuro Oncol. 2012 Dec;14 (12 ):1473-80
references.pmid: 23090986
references.citation: Neuro Oncol. 2011 Mar;13(3):307-16
references.pmid: 21292686
references.citation: Neurosurg Focus. 2015 Jan;38(1):E4
references.pmid: 25552284
references.citation: J Neurooncol. 2013 Jan;111(1):11-8
references.pmid: 23086431
references.citation: Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1561-7
references.pmid: 14579097
references.citation: Neurology. 1991 Nov;41(11):1741-4
references.pmid: 1658684
references.citation: Acta Neurochir Suppl. 1997;68:133-8
references.pmid: 9233429
references.citation: Nat Med. 1998 Nov;4(11):1334-6
references.pmid: 9809561